MedTrace Logo

Investigating the Efficacy of Combining Virtual Reality-Based Mirror Therapy (VRMT) and Transcranial Direct Current Stimulation (tDCS) to Improve Upper Limb Recovery in Patients with Stroke

NCT06764797 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-01-08

No results posted yet for this study

Summary

This study will investigate whether combining virtual reality-based mirror therapy (VRMT) and transcranial direct current stimulation (tDCS) alongside conventional physical therapy (CPT) will significantly improve hand function for patients with stroke compared to using VRMT or tDCS alone.

Conditions

Interventions

DEVICE

Transcranial Direct Current Stimulation

tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.

DEVICE

Virtual reality

The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.

DEVICE

Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy

20 minutes of tDCS during 45 minutes of VRMT games.

OTHER

Conventional physical therapy

45 minutes of conventional physical therapy with sham tDCS

Sponsors & Collaborators

  • King Fahad Medical City

    collaborator OTHER_GOV

  • King Saud Medical City

    collaborator OTHER_GOV

  • King Saud University

    lead OTHER

Principal Investigators

  • Alaa M. Albishi, Doctor of Philosophy · King Saud University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-19
Primary Completion
2025-05-31
Completion
2025-07-21

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06764797 on ClinicalTrials.gov